Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 8;19(11):e0312769.
doi: 10.1371/journal.pone.0312769. eCollection 2024.

Web-based interventions for fear of cancer recurrence: A scoping review with a focus on suggestions for the development and evaluation of future interventions

Affiliations

Web-based interventions for fear of cancer recurrence: A scoping review with a focus on suggestions for the development and evaluation of future interventions

Solveiga Zibaite et al. PLoS One. .

Abstract

Purpose: The objective of this scoping review is to provide an overview of the available evidence on the effectiveness of web-based interventions for fear of cancer recurrence (FCR) and a discussion of drawbacks and possible improvements for web-based interventions identified in the reviewed studies. These steps fulfil the aim of this review, which is to offer suggestions for developing future web-based interventions based on the reviewed studies.

Methods: Five databases (PubMed, MEDLINE, EMBASE, SCOPUS and Web of Science) were searched. Original peer-reviewed articles, written in English, on web-based interventions for FCR were included for review. The data from the included studies was synthesised thematically.

Results: We included 34 papers reporting on 28 interventions. Most of the studies in the papers were quantitative and mixed quantitative studies with a qualitative element, e.g. an interview post-intervention. Interventions were most commonly trialled with women breast cancer patients. Top three countries where studies were conducted were USA, Australia and the Netherlands. The most common theoretical framework for interventions is cognitive behavioural therapy (CBT), followed by mindfulness-based and mixed CBT, mindfulness, acceptance and commitment therapy (ACT), relaxation approaches. FCR was the primary focus/measure in 19 Studies, in 9 studies FCR was a secondary/related outcome/measure. Overall, the evidence of efficacy of web-based interventions on FCR is mixed.

Conclusions: The existing research suggests several key points for producing more robust evidence about the effectiveness of web-based interventions for FCR. First, the studies suggest that it is a priority to better define eligibility criteria to proactively include people with higher levels of FCR. Second, there is a need for longer-term follow-up and outcome measuring period. Third, research examining the reasons for dropout from web-based interventions for FCR is critical to improve the effectiveness of web-based interventions. Fourth, while web-based interventions do not involve the costs of transportation, traveling time, space, equipment, cleaning, and other expenses, further cost utility analyses should be performed. Finally, future studies should assess how intervention accessibility, adherence, and effectiveness can be improved across different intervention designs, varying from intensive synchronous individual therapist-assisted web-based programme to blended designs combining the advantages of face-to-face and internet-based elements, to entirely self-managed programmes.

Implications for cancer survivors: Developing and evaluating more accessible FCR treatments have been identified among top international FCR research priorities (Shaw et al. 2021). While there is some evidence that web-based interventions can be as effective as face-to-face interventions, currently there is a dearth of systematic data about the ways in which the web-based modality specifically can enhance supportive care for FCR. Developing knowledge about effective web-based interventions has implications for cancer survivors as they can be presented with more accessible, low-cost and low-burden options for managing fear of cancer recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Literature search flowchart.

References

    1. on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees, Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, et al.. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016. Aug;24(8):3265–8. doi: 10.1007/s00520-016-3272-5 - DOI - PubMed
    1. Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G, et al.. Identifying the key characteristics of clinical fear of cancer recurrence: An international Delphi study. Psychooncology. 2020. Feb;29(2):430–6. doi: 10.1002/pon.5283 - DOI - PubMed
    1. Coutts‐Bain D, Sharpe L, Pradhan P, Russell H, Heathcote LC, Costa D. Are fear of cancer recurrence and fear of progression equivalent constructs? Psychooncology. 2022. Aug;31(8):1381–9. doi: 10.1002/pon.5944 - DOI - PMC - PubMed
    1. Humphris GM, Watson E, Sharpe M, Ozakinci G. Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7. Health Qual Life Outcomes. 2018. Dec;16(1):30. doi: 10.1186/s12955-018-0850-x - DOI - PMC - PubMed
    1. Hall DL, Wagner LI, Lebel S, Smith A Ben, Bergerot CD, Park ER. Guidelines needed for the management of fear of cancer recurrence in adult survivors of cancer in the United States: A consensus statement. Cancer. 2024. Apr 17;cncr.35326. doi: 10.1002/cncr.35326 - DOI - PMC - PubMed

Publication types

LinkOut - more resources